A092040 Share Price Performance
Recent A092040 News & Updates
No updates
Amicogen, Inc. Key Details
Last Reported Earnings
Mar 31, 2025
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- -966.13
- Gross Margin
- 27.59%
- Net Profit Margin
- -35.25%
- Debt/Equity Ratio
- 93.4%
Amicogen, Inc. Competitors
About A092040
- Founded
- 2000
- Employees
- 225
- CEO
- WebsiteView website
Amicogen, Inc. operates as an industrial biotechnology company in South Korea and internationally. The company develops, produces, and sells of enzymes and new materials; and produces food-related additives and health functional food. It manufactures and sells of biopharmaceutical materials and resins for purifying pharmaceutical proteins and health and beauty products. In addition, the company offers oral incurable and rare disease treatments, as well as manufactures and sells of pharmaceutical raw materials, animal drugs, human drugs, etc. The company was incorporated in 2000 and is headquartered in Jinju-Si, South Korea.
South Korean Market Performance
- 7 Days: 1.9%
- 3 Months: 25.1%
- 1 Year: 14.3%
- Year to Date: 32.8%
The market is up 1.7% over the last week, with the Industrials sector leading the way, up 5.0%. Meanwhile, the Financials sector has underperformed, shrinking 3.2% in that time. The market is up 15% over the last 12 months. Earnings are forecast to grow by 21% annually. Market details ›
Companies across the globe are beginning to pay attention to agentic AI. It’s also a term you’re likely to hear a lot during earnings season. In fact, it came up 26 times during...
Continue reading